Background/objectives: Weight loss in obesity can reduce morbidity and mortality and benefits persist as long as weight loss is maintained. Weight maintenance is difficult in the long term and new strategies need to be developed to achieve this goal. We aimed to evaluate the efficacy of substituting a low-calorie diet formula for a meal in a weight loss program during the maintenance phase. Methods: Randomized paralleled clinical trial including 62 adult patients with at least a 5% weight loss with diet alone for 6 months, randomized to two groups: daily replacement of one meal with a low-calorie diet formula, or dieting alone for another 6 months (weight maintenance phase). Results: Weight maintenance or further weight loss occurred in 83.9% of patients in the intervention group, whereas only in 58.1% in the control group (P ¼ 0.025). As a whole, patients in the intervention group lost a further 3.2±3.7% of initial weight compared with a 1.3 ± 3.6% in the control group (P ¼ 0.030). Body fat mass diminished in both groups, with no differences between them (1.6±3.5 vs 1.0±9.3 kg, respectively, P ¼ 0.239), and the same happened with free fat mass (0.9±3.3 vs 0.4 ± 6.7 kg, respectively, P ¼ 0.471). A multivariate logistic regression analysis (R 2 ¼ 0.114, P ¼ 0.023) retained only the intervention as a predictor of the achievement of weight maintenance with an odds ratio (95% confidence interval) of 3.756 (1.138-12.391). Conclusions: Substitution of a low-calorie diet formula for a meal is an effective measure for weight loss maintenance compared with dieting alone.
Introduction
Overweight and obesity are the second leading cause of preventable death, primarily through cardiovascular disease risk factors (Flegal et al., 2005) . Weight loss in an overweight or obese individual can reduce these risk factors, and benefits persist as long as weight loss is maintained (Wood et al., 1988; Stevens et al., 2001; Knowler et al., 2002) .
Behavioral interventions for adults result in clinically significant weight loss, but weight loss maintenance is difficult (Jeffery et al., 2000; Dansinger et al., 2007) . A substantial number of patients regain all the weight they lose on diets, because of several factors such as hormonal and adaptive changes, psychological burden and the lack of longterm monitoring (Elfhag and Rossner, 2005; Wadden et al., 2005) . This difficulty in maintaining weight loss, might be due to the complexity and intensity of the mechanisms that are triggered when dieting, affecting energy balance, appetite control and neurohormonal responses (Weinsier et al., 2000; DelParigi et al., 2004) .
Predictors for successful long-term weight loss and maintenance are the consumption of a low-energy low-fat diet, high levels of physical activity, a self-regulation program for weight maintenance and close professional follow-up (Wing and Phelan, 2005; Wing et al., 2006; Jakicic et al., 2008) . Factors associated with weight regain in NHANES survey included Mexican-American ethnicity, loss of a greater percentage of maximum weight, sedentary lifestyle, and not meeting public health recommendations for physical activity (Weiss et al., 2007) .
Few studies focus on specific strategies for the maintenance phase. A self-regulation program based on daily weighing improved maintenance of weight loss , and personal contact intervention produced less weight regain (Svetkey et al., 2008) . Medications for obesity in weight maintenance have shown some efficacy, but with modest effects and at the expense of adverse events, as well as non-compliance and rebound weight regain (Hill et al., 1999; Gursoy et al., 2006; Franz et al., 2007) .
The non-medication strategies for weight loss include studies of meal replacement, as an effective additional aid. This strategy has shown significant sustainable weight loss and improved weight-related risk factors (Ashley et al., 2001; Heymsfield et al., 2003) . In this context we decided to evaluate a strategy for weight maintenance by meal replacement after successful initial weight loss with diet alone.
Patients and methods

Study objectives and participants
To evaluate the efficacy of substituting a low-calorie diet formula for a meal in a weight loss program during the maintenance phase, we included Caucasian adult patients between 18 and 75 years old, who have responded positively to a weight loss program during the induction phase (the previous 6 months) with at least a 5% weight loss from baseline. The maintenance phase was defined as that occurring from 6 months after initiating the weight loss program for an additional 6 months. Exclusion criteria were as follows: patients who have received any pharmacological therapy for weight loss, those with renal, hepatic, pulmonary or cardiovascular diseases, major depression, and pregnant or lactating women.
The Ethics Committee of the Hospital Ramon y Cajal approved the study and written informed consent was obtained from the participants.
Interventions
We used a randomized, controlled, open, paralleled two arms design. The intervention group received a low-calorie diet formula (Optifast, Nestlé Healthcare Nutrition, Vevey, Switzerland) instead of dinner everyday. The control group received no intervention apart from the prescribed diet, which was also given to the intervention group. The prescribed diet for both the weight loss induction phase and the maintenance phase aimed to a caloric restriction of 400-500 kcal/day. Estimated energy expenditure was calculated by the World Health Organization (WHO) formulae (FAO, 2001) . Distribution of carbohydrates, fat and proteins in the prescribed diets was 55, 30 and 15%, respectively. Patients in both arms also attended to monthly interviews with a dietitian, one of the researchers (C Montagna), for nutritional counseling, and at these time points anthropometric variables were also recorded.
Outcomes
The primary outcome was the percentage of patients able to maintain earlier weight loss or to lose further weight in the maintenance phase of a weight loss program at our Institution either with diet alone (controls) or with the intervention. Secondary outcomes included changes in body composition, blood pressure and biochemical variables related to glucose and lipid metabolism, among other obesity-related comorbidities.
At baseline, and after a 12 h overnight fast, basal blood samples were obtained from each patient. Determinations included fasting glucose, creatinine, liver function enzymes and lipid profiles, using an automated analyzer (Abbott Architect 16,200 Automated Instrument Analyzer, Abbott Laboratories, Abbott Park, IL, USA). Weight and height of each patient were recorded and body mass index calculated. Body composition was estimated by bioelectrical impedance analysis (Tanita TBF-300A, Tanita Corporation of America Inc., Arlington Heights, IL, USA). Blood testing was repeated at the end of the study.
Patients were followed-up at month intervals throughout the study. At baseline and at the end of the study, the aforementioned variables were determined and recorded. At intermediate visits anthropometric variables were recorded, and patients were asked about any possible adverse events.
Sample size, randomization and implementation A priori power analysis was performed using the Ene 2.0 software (http://www.ene-ctm.com, Universitat Autó noma Barcelona, Spain). Assuming that in the control group 40% of patients would maintain or further lose weight, and 75% in the intervention group would achieve this goal, 31 patients in each group would be needed for a b of 0.2 and a of 0.05.
A total of 65 eligible patients were enrolled, of whom 62 consenting patients were randomized using sealed opaque envelopes to yield two groups with 31 patients each. The investigators who designed the study prepared the envelopes and assigned participants to their groups, but had no contact with the patients throughout the study. The investigator administering the interventions, performing the follow-up, and evaluating the outcomes had no role in the randomization process.
Adherence to both the intervention and the prescribed diet was assessed by the latter investigator in monthly interviews by 24 h dietary recall and also semiquantitative estimation of the ingestion in the previous month. Patients were dropped from the study if they took less than 25% of the prescribed low-calorie diet formula or if the adherence to diet was less than 80%.
Statistical analyses
Results are expressed as means±s.d. unless otherwise stated. The Kolmogorov-Smirnov statistic was applied to continuous variables. Logarithmic or square-root transformations were applied as needed to ensure a normal distribution of the variables. Intention to treat analysis was performed with the last observation carried forward.
Comparisons between groups were performed using unpaired t-test for continuous variables or the MannWhitney U-test for non-normal distributed variables, and the w 2 -test or Fisher's exact test for discontinuous variables, as needed. Changes in several variables were also expressed as percentage of the baseline values.
The general linear model (GLM)-repeated measures test was used for the comparison of continuous variables throughout the study, introducing the studied variable at different time points as the within-subject factor and the intervention group as the between-subject factor, and the interaction between them. Before these calculations, sphericity was ensured by Mauchly's test.
Backwards stepwise multiple logistic regression model (probability of F to remove X0.1) was used to study the effects of multiple independent variables on the achievement of the primary outcome. Analyses were performed using SPSS 12 (SPSS Inc., Chicago, IL, USA). Po0.05 was considered statistically significant.
Results
Of the 62 randomized patients, eight patients did not complete the study, four in each group. The first four patients allocated to the control group did not attend the last visit. Of the other four patients allocated to the intervention group, one did not adhere correctly to the treatment and the other three did not attend the last visit (Figure 1 ). A total of 54 patients completed the study, and the intention to treat analysis was performed with the last observation carried forward.
Basal characteristics of the patients included in the study are shown in Table 1 . Patients in both groups presented with a similar percentage of weight loss in the induction phase. However, randomization of patients was not effective in segregating patients in the two groups with similar adiposity, as patients in the control group had higher body mass index, waist circumference and estimated body fat mass (Table 1) .
Primary outcome
Of the 31 patients randomized to the intervention group, 26 (83.9%) maintained or lost further weight during the maintenance phase, whereas only 18 (58.1%) patients in the control group did so (w 2 ¼ 5.010, P ¼ 0.025) (Figure 2 ).
Secondary outcomes
Patients in the intervention group lost a further 3.2±3.7% of initial weight compared with patients in the control group who lost 1.3 ± 3.6% of initial weight at the entry of study (Mann-Whitney U ¼ 326.5, P ¼ 0.030) (Figure 3 ). When absolute weight loss was analyzed, a higher reduction in absolute weight, although not significant, was also observed in the intervention group compared with the control group (3.1±3.3 vs 1.6±3.9 kg, respectively, F ¼ 3.911, P ¼ 0.053 for the interaction between visits and treatment group). Body fat mass diminished throughout the study in both groups, with no differences between the control and the intervention groups (1.0±9.3 vs 1.6±3.5 kg, respectively, Mann-Whitney U ¼ 397.0, P ¼ 0.239), and the same happened with the free fat mass (0.4 ± 6.7 vs 0.9 ± 3.3 kg respectively, Mann-Whitney U ¼ 429.5, P ¼ 0.471).
Changes in other secondary outcomes are presented in Table 2 . There were no differences in changes in waist circumference, blood pressure, fasting glucose, lipid profiles or other biochemical parameters between controls and patients allocated to the intervention (nonsignificant interactions between time and group of intervention for all these variables). Waist circumference diminished (Wilks l ¼ 0.792, F ¼ 15.218, Po0.001) and high-density lipoprotein concentrations increased (Wilks l ¼ 0.741, F ¼ 13.961, P ¼ 0.001) with time (significant within-subject effects) in the studied patients (Table 2) .
Patients initially randomized (n=62)
Intervention group
No intervention (n=31)
Lost to followup (n=4)
Lost to follow-up (n=3) Lack of adherence (n=1) 27 patients 27 patients
Intention to treat analysis (n=62) Figure 1 Flow of the study.
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Ancillary analyses
When considering only those patients who achieved the primary outcome, there were no differences between the control and the intervention groups in changes in body fat mass (1.0 ± 9.9 vs 1.8 ± 3.4 kg, respectively, Mann-Whitney U ¼ 222.0, P ¼ 0.774) or free fat mass (0.7 ± 5.1 vs 1.5 ± 3.2 kg, respectively, Mann-Whitney U ¼ 176.0, P ¼ 0.164). Furthermore, there were no differences in changes in waist circumference, blood pressure, fasting glucose, lipid profiles, or other biochemical parameters between controls and patients allocated to the intervention (nonsignificant interactions between time and group of intervention for all these variables).
A multivariate logistic regression analysis was performed with a backward stepwise modeling in which the achievement or not of the primary outcome was introduced as the dependent variable. Sex, age, group of intervention, initial body weight before the induction phase, baseline body weight at entry of study and percentage of weight loss in the induction phase were introduced as covariates. The model retained only the intervention as a predictor of the achievement of the primary outcome (odds ratio (95% CI) ¼ 3.756 (1.138-12.391), Nagelkerke R 2 ¼ 0.114,
Adherence and adverse events Adherence to the prescribed diet throughout the study in both the intervention and the control group was above 80% in both groups, as assessed by the dietitian. Adherence to the prescribed low-calorie diet in the intervention group was complete except in one patient who did not substitute the low-calorie diet for the meal on several occasions and was removed from the study. Patients allocated to the intervention group did not present reported adverse events. Figure 2 The primary outcome. Bars represent the absolute number of patients in each group who attained or did not attain the primary outcome of maintaining or further losing weight during the maintenance phase. Gray bars represent the patients who did not maintain or lose further weight and black bars those who attained the primary outcome. *P ¼ 0.025 between controls and patients in the intervention group.
Discussion
We have shown that substitution of a low-calorie diet formula for a meal is an effective measure for weight loss maintenance compared with dieting alone. Patients in the intervention group were able to maintain weight loss to a greater extent, lost more than twice the weight than the controls, and this was achieved without a higher loss in lean body mass. As weight maintenance is very important to reduce the cardiovascular risk factors associated with obesity (Wood et al., 1988; Stevens et al., 2001; Knowler et al., 2002) , the strategy used in our study is of interest for clinical practice. Although the difference of the mean percentage weight loss between both groups was only of 1.9% of the initial body weight, total weight loss from the beginning of the induction phase was of more than 10% in the intervention group. It has been shown that each kilogram of weight loss is associated with a reduction of incident diabetes of 16% (Hamman et al., 2006) , and that even modest weight loss can improve cardiovascular risk factors (Wood et al., 1988; Neter et al., 2003) . Therefore, the difference found between both groups in our study is not only statistically significant, but can be also considered of clinical relevance. Moreover, it has been shown that a 10% weight loss, as achieved by the intervention group in our study, is associated with a very important reduction in morbidity and mortality (Jung, 1997) .
When compared with other strategies used for weight maintenance, substitution of a low-calorie diet formula for a meal, as shown in our study, is of similar or higher efficacy. In a study in which patients were treated with orlistat for 1 year after initial successful weight loss for 6 months without medication, 67% were able to maintain of further lose weight, whereas only 41% in the placebo group did so (Hill et al., 1999) . In other study, 43% of patients on daily sibutramine were able to maintain or further lose weight, whereas only 16% in the placebo group did so (James et al., 2000) . In this trial, the percentage of patients who were able to maintain initial weight loss decreased with time, and there were also many drops (Hill et al., 1999; James et al., 2000) , so it seems that weight maintenance is difficult to achieve in every patient even with pharmacological aid in the long run. One limitation of our study is the fact that the weight maintenance phase included only 6 months after the initial induction phase. Anyway, substitution of a low-calorie diet formula for a meal for weight maintenance is well tolerated, with no adverse events, very good adherence and at least a similar efficacy than the pharmacological approach, and with lower costs.
Weight maintenance in non-pharmacological studies was higher in personal contact intervention than other strategies (Svetkey et al., 2008) . However, patients in this group already regain more than 1 kg in the first 6 months of the maintenance phase (Svetkey et al., 2008) . In other study , 319 adults who reported losing at least 10% of body weight within the previous 2 years were randomly assigned to face-to-face contact, internet intervention or none for 18 months. There was a 2.5 kg weight regain in the face-to-face intervention, but at the first 6 months interval, these patients were able to lose 0.02 kg. In our study, mean weight loss in the intervention group was 3.2 kg and in the placebo group 1.3 Kg in the maintenance phase. Personal face-to-face interviews with careful review of protocol and diet adherence might have been responsible for the differences between our study and the other two ones, making our intervention more effective in terms of weight maintenance. Earlier studies with meal substitution have used this approach from the beginning of the induction phase, showing a higher weight loss when compared with only diet in 6 months and 1 year studies (Heymsfield et al., 2003; Wal et al., 2007; Cheskin et al., 2008; Konig et al., 2008) , and also more beneficial changes in cardiovascular risk factors (Konig et al., 2008) . Although other authors have failed to show differences between meal replacement strategies and dieting alone (Noakes et al., 2004; Ashley et al., 2007) , overall evidence suggests that meal replacement strategies are effective for weight loss in the induction and posterior maintenance phase (Heymsfield et al., 2003) . Furthermore, our study suggest that even in those patients who initially respond to dieting alone without meal replacement, a strategy of meal replacement in the maintenance phase is very effective compared with dieting alone, and this represents a new evidence-based approach of clinical interest.
Meal replacement together with medications for obesity has also been tested for weight loss induction and maintenance. The efficacy and safety of sibutramine with a lowcalorie diet and commercial meal replacement product in achieving weight loss and maintenance in obese patients was tested in one study (Early et al., 2007) . A 85% of sibutramine patients maintained at least 80% of their initial weight loss compared with only 37% in the placebo group. However, the differences may have been explained by a rebound in weight after sibutramine withdrawal in the placebo group. Another study aimed to compare the use of meal replacement or orlistat during weight maintenance showed (LeCheminant et al., 2005) that both interventions were equally effective in maintaining weight significantly below baseline levels over a 52-week period (LeCheminant et al., 2005) . However, in this study, failure of both medication and meal replacement to achieve further weight loss in the maintenance phase might have been due to the fact that weight loss was very intense in the induction phase (Weiss et al., 2007) , of more than 22 kg in both groups. We believe that a less intense but progressive weight loss in the induction phase may also achieve higher rates of weight maintenance, and even further weight loss in the long term, as occurred in our study.
In conclusion, substitution of a low-calorie diet formula for a meal is an effective measure for weight loss maintenance compared with dieting alone after an initial successful weight loss induction with diet alone. Future studies should address the efficacy of this intervention in the long term.
